.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Analyze global market entry opportunities
  • Predict branded drug patent expiration

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
McKesson
Baxter
Teva
Moodys
Merck
Express Scripts
Johnson and Johnson
Novartis
Dow

Generated: July 24, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 202895

« Back to Dashboard
NDA 202895 describes PREZISTA, which is a drug marketed by Janssen Prods and is included in two NDAs. It is available from five suppliers. There are nine patents protecting this drug and two Paragraph IV challenges. Additional details are available on the PREZISTA profile page.

The generic ingredient in PREZISTA is darunavir ethanolate. There are twenty-four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the darunavir ethanolate profile page.

Summary for NDA: 202895

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Antivirals
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 202895

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PREZISTA
darunavir ethanolate
SUSPENSION;ORAL 202895 NDA Janssen Products LP 59676-565 59676-565-01 200 mL in 1 BOTTLE, GLASS (59676-565-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:SUSPENSION;ORALStrengthEQ 100MG BASE/ML
Approval Date:Dec 16, 2011TE:RLD:Yes
Patent:► SubscribePatent Expiration:Dec 26, 2016Product Flag?Substance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Dec 26, 2016Product Flag?Substance Flag?Delist Request?
Patent:► SubscribePatent Expiration:Dec 23, 2019Product Flag?Substance Flag?Delist Request?Y

Expired Orange Book Patents for NDA: 202895

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Prods
PREZISTA
darunavir ethanolate
SUSPENSION;ORAL202895-001Dec 16, 2011► Subscribe► Subscribe
Janssen Prods
PREZISTA
darunavir ethanolate
SUSPENSION;ORAL202895-001Dec 16, 2011► Subscribe► Subscribe
Janssen Prods
PREZISTA
darunavir ethanolate
SUSPENSION;ORAL202895-001Dec 16, 2011► Subscribe► Subscribe
Janssen Prods
PREZISTA
darunavir ethanolate
SUSPENSION;ORAL202895-001Dec 16, 2011► Subscribe► Subscribe
Janssen Prods
PREZISTA
darunavir ethanolate
SUSPENSION;ORAL202895-001Dec 16, 2011► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Teva
Johnson and Johnson
Harvard Business School
Federal Trade Commission
Colorcon
Deloitte
McKinsey
Queensland Health
Healthtrust
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot